Literature DB >> 9712619

European register of patients with sickle cell disease treated with hydroxyurea is being set up.

S C Davies, M Roberts-Harwood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9712619      PMCID： PMC1113770          DOI： 10.1136/bmj.317.7157.541a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Hydroxyurea therapy for sickle cell disease in Britain. Disappointing recruitment despite promising results.

Authors:  A Olujohungbe; K I Cinkotai; A Yardumian
Journal:  BMJ       Date:  1998-06-06

Review 2.  Implications of socio-cultural contexts for the ethics of clinical trials.

Authors:  R E Ashcroft; D W Chadwick; S R Clark; R H Edwards; L Frith; J L Hutton
Journal:  Health Technol Assess       Date:  1997       Impact factor: 4.014

3.  Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Authors:  S Charache; M L Terrin; R D Moore; G J Dover; F B Barton; S V Eckert; R P McMahon; D R Bonds
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245
  3 in total
  1 in total

1.  Register cannot replace prospective studies in sickle cell disease.

Authors:  A Yardumian; A Olujohungbe; K Cinkotai
Journal:  BMJ       Date:  1999-03-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.